More about

Insulin Delivery

News
May 18, 2020
3 min read
Save

Are better insulins still needed?

Are better insulins still needed?

Many people with type 2 diabetes are only on a basal insulin and are more dependent on noninsulin therapies, and with the advent of additional noninsulin options, such as GLP-1 receptor agonists or SGLT2 inhibitors, their outcomes are improving. There is a community out there that feels that insulins are as good as they can be.

News
February 22, 2020
3 min read
Save

Insulet announces partnerships with Abbott, Dexcom for its tubeless artificial pancreas system

Insulet announces partnerships with Abbott, Dexcom for its tubeless artificial pancreas system

Insulet this week announced separate partnerships with Abbott and Dexcom to integrate continuous glucose monitoring technology with its tubeless artificial pancreas system, according to industry press releases.

News
February 12, 2020
1 min read
Save

Medtronic recalls some MiniMed insulin pumps for incorrect dosing

Medtronic recalls some MiniMed insulin pumps for incorrect dosing

Medtronic has recalled its 600 series of MiniMed insulin pumps due to a missing or broken retainer ring, which helps to lock the insulin cartridge in place in the pump’s reservoir compartment, according to the FDA.

News
February 07, 2020
2 min read
Save

Insulin aspart biosimilar safe for pump therapy use in type 1 diabetes

Insulin aspart biosimilar safe for pump therapy use in type 1 diabetes

A follow-on therapy to insulin aspart was shown to be safe and effective for pump use among adults with type 1 diabetes, with no increased incidence of unexplained hypoglycemia when compared with the reference product, according to findings from an open-label crossover study published in Diabetes Technology & Therapeutics.

News
January 16, 2020
2 min read
Save

Mobile closed-loop insulin system bests sensor-augmented pump in preventing hypoglycemia

Mobile closed-loop insulin system bests sensor-augmented pump in preventing hypoglycemia

Patients with type 1 diabetes may be able to avoid hypoglycemia more effectively without an increase in hyperglycemic episodes if they use a mobile closed-loop control system instead of a sensor-augmented pump, according to findings published in Diabetes Care.

News
January 06, 2020
1 min read
Save

FDA approves rapid-acting insulin for children with diabetes

FDA approves rapid-acting insulin for children with diabetes

The FDA on Monday approved fast-acting insulin aspart 100 U/mL as a mealtime insulin for children with diabetes, according to a press release from Novo Nordisk.

News
January 02, 2020
2 min read
Save

Top diabetes device news of 2019: ‘digiceuticals,’ interoperable devices, insurance coverage and more

Top diabetes device news of 2019: ‘digiceuticals,’ interoperable devices, insurance coverage and more

In 2019, Healio readers were interested in advancements in design and regulation of devices and apps that can work alone or together to help manage diabetes. Insurance coverage for diabetes devices and finding the right device for individuals with diabetes remain issues. 

News
December 27, 2019
4 min read
Save

High discontinuation rate for artificial pancreas among youths with type 1 diabetes

High discontinuation rate for artificial pancreas among youths with type 1 diabetes

Approximately half of children and young adults with type 1 diabetes who initiated use of a hybrid closed-loop insulin delivery system, also known as an artificial pancreas, were still using the device in auto mode after 6 months, with 30% of youths discontinuing use of the system altogether, according to findings from a real-world study published in Pediatric Diabetes.

News
December 23, 2019
2 min read
Save

Bionic pancreas receives FDA breakthrough device designation

Bionic pancreas receives FDA breakthrough device designation

The FDA has granted breakthrough device designation to an investigational bionic pancreas system, according to a press release from Beta Bionics.

News
December 16, 2019
5 min read
Save

Noninjectable options to deliver insulin, manage diabetes

Noninjectable options to deliver insulin, manage diabetes

LOS ANGELES — Several cutting-edge advances in noninjectable insulin delivery methods could offer new ways for people with diabetes to manage the disease and better control glucose response, with the possibility of an oral insulin formulation closer than ever before to becoming reality, according to a speaker at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.

View more